Cure SMA Funds Over $9 Million in New and Ongoing Research in FY20

During our past fiscal year—from July 1, 2019 to June 30, 2020—Cure SMA funded more than $9 million in new and ongoing research and care initiatives. This money will be used strategically to help accelerate research and ensure we are developing treatments and protocols for all types, ages, and stages of spinal muscular atrophy (SMA). […]

Cure SMA Funds Over $9 Million in New and Ongoing Research in FY20 Read More »

Community Spotlight: The Hoskin Family

High school sweethearts, Steven and Amy Hoskin, and their 19-month-old son, Grayson, reside outside Sacramento, CA. Steven describes them as a goofy bunch, always playing practical jokes on each other. Grayson is quick to acclimate to his family’s cheerful demeanor and loves to join in on the silliness. Grayson has been through a lot for

Community Spotlight: The Hoskin Family Read More »

Cure SMA, Novartis Publish Economic Burden of SMA Analysis in Journal of Market Access & Health Policy

Recently, Cure SMA and colleagues at Novartis Gene Therapies published a manuscript titled, “Economic burden of spinal muscular atrophy: an analysis of claims data” in the Journal of Market Access & Health Policy. The purpose of the manuscript was to describe an analysis that was conducted measuring direct costs related to spinal muscular atrophy (SMA)

Cure SMA, Novartis Publish Economic Burden of SMA Analysis in Journal of Market Access & Health Policy Read More »

Answering Questions about COVID-19 Vaccination and SMA

To the full spinal muscular atrophy (SMA) community, we want you to know that Cure SMA is continuing to support you with information and resources related to the COVID-19 pandemic. The following frequently asked questions (FAQs) are designed to help address key concerns expressed by members of the SMA community about COVID-19 vaccination and provide

Answering Questions about COVID-19 Vaccination and SMA Read More »

Cure SMA Shares Perspective on COVID-19 Vaccination

Dear SMA Community, Although this year has brought with it many challenges, the SMA community continues to demonstrate its strength and resilience. Cure SMA remains committed to bringing you the information, resources, and support you need as we continue to navigate the COVID-19 pandemic. Last week, the Advisory Committee on Immunization Practices (ACIP)—a U.S. Centers

Cure SMA Shares Perspective on COVID-19 Vaccination Read More »

Biogen SMA Q4 2020 Community Statement

Dear Members of the SMA Community, As we celebrate National Family Caregivers Month this November, Biogen acknowledges the vital role caregivers have in our society, including within our spinal muscular atrophy (SMA) community. We also recognize that caregivers need our support more than ever. Caregivers in the SMA community face an especially unique set of

Biogen SMA Q4 2020 Community Statement Read More »

Results from Annual SMA Community Update Survey Now Published

Each year since 2017, Cure SMA has conducted a Community Update Survey. This online questionnaire is sent to all individuals with spinal muscular atrophy (SMA) and caregivers of children with SMA in the Cure SMA database to capture self- and caregiver-reported data on disease characteristics and health outcomes. Cure SMA uses data collected through the

Results from Annual SMA Community Update Survey Now Published Read More »

Cure SMA Announces Two New Virtual Programs for Adults with SMA

Cure SMA is excited to be announcing—along with support from Biogen—the launch of two new programs for adults with SMA. First, we will test your knowledge of random (and useless) facts with an Adults with SMA Virtual Trivia Night. Then, in the coming months, we will begin hosting an Adults with SMA Virtual Book Club.

Cure SMA Announces Two New Virtual Programs for Adults with SMA Read More »

Scroll to Top